Katrien Vermeiren

528 total citations
5 papers, 346 citations indexed

About

Katrien Vermeiren is a scholar working on Epidemiology, Hepatology and Oncology. According to data from OpenAlex, Katrien Vermeiren has authored 5 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Epidemiology, 3 papers in Hepatology and 2 papers in Oncology. Recurrent topics in Katrien Vermeiren's work include Hepatitis B Virus Studies (3 papers), Hepatitis C virus research (3 papers) and Cancer Genomics and Diagnostics (1 paper). Katrien Vermeiren is often cited by papers focused on Hepatitis B Virus Studies (3 papers), Hepatitis C virus research (3 papers) and Cancer Genomics and Diagnostics (1 paper). Katrien Vermeiren collaborates with scholars based in Sweden and Belgium. Katrien Vermeiren's co-authors include Pierre Raboisson, Kenneth Simmen, Tse‐I Lin, Oliver Lenz, Annick Scholliers, Thierry Verbinnen, Lotta Vrang, Herman de Kock, Michael Edlund and Gregory Fanning and has published in prestigious journals such as Cancer Research, Antimicrobial Agents and Chemotherapy and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Katrien Vermeiren

4 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Katrien Vermeiren Sweden	4	285	222	170	40	29	5	346
Annick Scholliers United States	9	385 1.4×	320 1.4×	197 1.2×	49 1.2×	34 1.2×	11	500
Patricia McMonagle United States	11	233 0.8×	193 0.9×	156 0.9×	35 0.9×	12 0.4×	17	294
Michelle Irvin United States	11	583 2.0×	479 2.2×	305 1.8×	54 1.4×	30 1.0×	17	665
Velia Chiara Di Maio Italy	10	247 0.9×	240 1.1×	205 1.2×	50 1.3×	16 0.6×	28	396
Roel Sentjens Netherlands	8	344 1.2×	305 1.4×	114 0.7×	29 0.7×	49 1.7×	12	400
Ellen Xia United States	9	271 1.0×	205 0.9×	167 1.0×	24 0.6×	35 1.2×	13	296
Frédéric Delouvroy Sweden	4	141 0.5×	97 0.4×	74 0.4×	50 1.3×	24 0.8×	5	210
Monica Bisbocci Italy	7	222 0.8×	165 0.7×	148 0.9×	106 2.6×	27 0.9×	10	336
Susan Chaniewski United States	7	265 0.9×	244 1.1×	161 0.9×	52 1.3×	9 0.3×	10	378

Countries citing papers authored by Katrien Vermeiren

Since Specialization

Citations

This map shows the geographic impact of Katrien Vermeiren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katrien Vermeiren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katrien Vermeiren more than expected).

Fields of papers citing papers by Katrien Vermeiren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katrien Vermeiren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katrien Vermeiren. The network helps show where Katrien Vermeiren may publish in the future.

Co-authorship network of co-authors of Katrien Vermeiren

This figure shows the co-authorship network connecting the top 25 collaborators of Katrien Vermeiren. A scholar is included among the top collaborators of Katrien Vermeiren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katrien Vermeiren. Katrien Vermeiren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Vandenbroucke, Ina, Katrien Vermeiren, Elisa Mokany, et al.. (2014). Abstract 1502: A rapid and fully automated multiplex assay for KRAS-BRAF mutations with high mutation sensitivity using novel selective amplification and detection technologies. Cancer Research. 74(19_Supplement). 1502–1502. 1 indexed citations

2.

Ivens, Tania, et al.. (2013). Expression and Purification of Dengue Virus NS5 Polymerase and Development of a High-Throughput Enzymatic Assay for Screening Inhibitors of Dengue Polymerase. Methods in molecular biology. 1030. 237–247. 14 indexed citations

3.

Lenz, Oliver, Thierry Verbinnen, Tse‐I Lin, et al.. (2010). In Vitro Resistance Profile of the Hepatitis C Virus NS3/4A Protease Inhibitor TMC435. Antimicrobial Agents and Chemotherapy. 54(5). 1878–1887. 178 indexed citations

4.

Lin, Tse‐I, Oliver Lenz, Gregory Fanning, et al.. (2009). In Vitro Activity and Preclinical Profile of TMC435350, a Potent Hepatitis C Virus Protease Inhibitor. Antimicrobial Agents and Chemotherapy. 53(4). 1377–1385. 142 indexed citations

5.

Raboisson, Pierre, Oliver Lenz, Tse‐I Lin, et al.. (2007). Evaluation of the anti-hepatitis C virus effect of novel potent, selective, and orally bioavailable JNK and VEGFR kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(7). 1843–1849. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact